IART Logo

Integra LifeSciences Holdings Corporation (IART) 

NASDAQ
Market Cap
$1.9B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
102 of 971
Rank in Industry
7 of 120

Largest Insider Buys in Sector

IART Stock Price History Chart

IART Stock Performance

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Insider Activity of Integra LifeSciences Holdings Corporation

Over the last 12 months, insiders at Integra LifeSciences Holdings Corporation have bought $2.5M and sold $331,193 worth of Integra LifeSciences Holdings Corporation stock.

On average, over the past 5 years, insiders at Integra LifeSciences Holdings Corporation have bought $1.45M and sold $63.15M worth of stock each year.

Highest buying activity among insiders over the last 12 months: ESSIG STUART (Exec. Chairman of the Board) — $4.5M. HILL BARBARA B (director) — $995,816.

The last purchase of 52,641 shares for transaction amount of $1.5M was made by ESSIG STUART (Exec. Chairman of the Board) on 2024‑05‑23.

List of Insider Buy and Sell Transactions, Integra LifeSciences Holdings Corporation

2024-08-19SaleSVP, Fin & Princ Acct Officer
1,191
0.0015%
$21.58$25,701-9.51%
2024-05-23PurchaseExec. Chairman of the Board
52,641
0.0668%
$28.49$1.5M-22.53%
2024-05-21Purchasedirector
36,350
0.0462%
$27.40$995,816-17.66%
2024-03-06SaleEVP & President, TT
8,348
0.0109%
$36.59$305,492-26.06%
2023-08-09SaleSVP, Fin & PAO
1,177
0.0014%
$44.46$52,329-14.14%
2023-06-01PurchaseEVP, Chief Legal Officer & Sec
2,640
0.0032%
$37.89$100,035+2.88%
2023-06-01PurchasePresident & CEO
7,792
0.0095%
$38.50$299,986+2.88%
2023-03-07SaleEVP & President, CSS
1,843
0.0023%
$54.29$100,064-22.92%
2023-03-01SaleEVP & President, TT
1,566
0.0019%
$55.21$86,463-23.04%
2023-02-27SaleEVP & CHRO
3,767
0.0046%
$57.00$214,731-25.99%
2022-12-08SaleSVP, Fin & Princ Acct Officer
279
0.0003%
$56.22$15,684-21.21%
2022-08-10SaleExecutive Vice President &CHRO
1,165
0.0014%
$55.81$65,020-6.92%
2022-08-05Sale
8,000
0.0096%
$55.78$446,266-5.72%
2022-08-02SaleSVP, Fin & Princ Acct Officer
437
0.0005%
$56.77$24,811-5.27%
2022-06-15SaleExecutive Vice President &CHRO
900
0.0011%
$55.93$50,337-3.92%
2022-05-24SaleExecutive Vice President &CHRO
250
0.0003%
$59.85$14,963-8.85%
2022-04-04SaleExecutive Vice President & COO
6,268
0.0077%
$66.04$413,939-14.16%
2022-03-23Sale10 percent owner
150,000
0.1845%
$64.67$9.7M-11.66%
2022-02-28SaleExecutive Vice President &CHRO
1,254
0.0015%
$67.03$84,056-16.22%
2022-02-09Sale10 percent owner
75,000
0.0891%
$65.82$4.94M-15.02%

Insider Historical Profitability

8.57%
ESSIG STUARTExec. Chairman of the Board
487922
0.6323%
$24.58174
DAVIS ROBERT T. JR.EVP & President, TT
49893
0.0647%
$24.5805
HILL BARBARA Bdirector
36350
0.0471%
$24.5840+10.78%
Mosebrook JeffreySVP, Fin & Princ Acct Officer
36088
0.0468%
$24.58010
CARUSO RICHARD E10 percent owner
10291205
13.3369%
$24.58112+23.04%
Tru St Partnership, L.P.10 percent owner
8515930
11.0362%
$24.5809
SOROS GEORGE10 percent owner
2725300
3.5319%
$24.58017
Arduini Peter JPresident & CEO
216713
0.2808%
$24.58014
SULLIVAN JAMES Mdirector
59604
0.0772%
$24.5808
Schwartz EricEVP, Chief Legal Officer & Sec
48597
0.063%
$24.5813+2.88%
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
42473
0.055%
$24.5807
Coleman GlennExecutive Vice President & COO
41288
0.0535%
$24.58016
Murphy Raymond G.
40825
0.0529%
$24.5807
MOREL DONALD E JRdirector
37112
0.0481%
$24.5820+6.47%
BRADLEY KEITHdirector
37065
0.048%
$24.5808
HENNEMAN JOHN B IIICorpVP, CAO
34159
0.0443%
$24.58054
PALTRIDGE ROBERT DCorp VP, Pres. Extrem Recon
33590
0.0435%
$24.5804
SCHADE CHRISTIAN Sdirector
32633
0.0423%
$24.5804
McBreen Michael J.EVP & President, CSS
28796
0.0373%
$24.5805
GORELICK RICHARD D.Corp VP, Gen Counsel & Sec
21565
0.0279%
$24.5806
NOCIOLO DON RSenior VP, Operations
18984
0.0246%
$24.5807
Evoli LisaEVP & CHRO
18605
0.0241%
$24.58012
MOORADIAN JOHNCorp VP, Global Ops & Supp Chn
15410
0.02%
$24.5805
De Witte JanPresident & CEO
12798
0.0166%
$24.5810+2.88%
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
12465
0.0162%
$24.5801
HOLTZ DAVID BSenior VP, Finance (1)
10248
0.0133%
$24.5806
LEONETTI DEBORAH ACorp VP, Glbl Servs & Repair
8715
0.0113%
$24.58011
Corbin Jerry ECorp VP & Corporate Controller
8677
0.0112%
$24.5804
VINHAIS JOSEPHCorp VP,Quality&Transformation
8231
0.0107%
$24.5804
CARLOZZI GERARD SExecutive Vice President & COO
7813
0.0101%
$24.58021
OGRADY JUDITHCorpVP,Reg.Affairs,CorpCompli
7206
0.0093%
$24.58041
LARKIN BRIANCorp VP, Pres.Gbl Spine &Ortho
7069
0.0092%
$24.5804
Ballintyn Rhonda Germanydirector
3665
0.0047%
$24.5810+3.09%
MOSZKOWSKI NEALdirector
3511
0.0046%
$24.5802
VANLENT ANNEdirector
3478
0.0045%
$24.5801
PIERSHBACHER MICHAELSenior V.P.., R&D
0
0%
$24.5804

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$247.47M8.866.98M-0.46%-$1.14M0.01
BlackRock$235.66M8.446.65M+0.09%+$209,615.850.01
Capital Research Global Investors$209.83M7.515.92M+37.74%+$57.49M0.05
Morgan Stanley$174.22M6.244.91M-6.76%-$12.63M0.01
Wellington Management Company$118.35M4.243.34M+4.81%+$5.43M0.02
AllianceBernstein$114.16M4.093.22M+18.15%+$17.54M0.04
Cooke & Bieler, L.P.$110.8M3.973.13M+10.27%+$10.31M1.02
Champlain Investment Partners, LLC$95.29M3.412.69M+10.35%+$8.93M0.55
State Street$75.1M2.692.12M+0.12%+$91,106.50<0.01
Dimensional Fund Advisors$62.83M2.251.77M+9.73%+$5.57M0.02
Deerfield Management$52.22M1.871.47M+30.48%+$12.2M0.13
Geode Capital Management$46.82M1.681.32M+5.12%+$2.28M<0.01
Macquarie Group$25.63M0.92723,088-18.7%-$5.9M0.02
GW&K Investment Management$24.8M0.89699,515+0.86%+$211,354.550.22
The Manufacturers Life Insurance Company$23.13M0.83652,549-8.77%-$2.22M0.02
Neuberger Berman$22.83M0.82644,572+28.8%+$5.11M0.02
Charles Schwab$21.18M0.76597,584+6.03%+$1.2M0.01
Goldman Sachs$21.03M0.75593,112-9.05%-$2.09M<0.01
BNY Mellon$20.93M0.75590,532-11.6%-$2.75M<0.01
Voloridge Investment Management, LLC$20.25M0.73571,320+84.1%+$9.25M0.08
Two Sigma Advisers LP$20.08M0.72566,300+1.6%+$315,505.000.03
Boston Partners$19.38M0.71561,942New+$19.38M0.02
Royal Bank of Canada$19.36M0.69546,070-0.15%-$29,848.620.01
Northern Trust$18.9M0.68533,028-10.49%-$2.21M<0.01
D. E. Shaw & Co.$18.43M0.66519,795+26.21%+$3.83M0.02
Point72 Europe London Llp$17M0.61479,635-33.35%-$8.51M1.63
Leeward Investments Llc Ma$16.04M0.57452,438+17.76%+$2.42M0.72
Two Sigma$15.69M0.56442,616+64.09%+$6.13M0.02
Fuller & Thaler Asset Management, Inc.$15.63M0.56440,870-47.58%-$14.19M0.07
Wells Fargo$15.38M0.55433,727-21.27%-$4.15M<0.01
Bank of America$14.68M0.53414,033-4.36%-$669,473.21<0.01
Invesco$14.26M0.51402,254+142.5%+$8.38M<0.01
Fisher Asset Management Llc$14.05M0.5396,194-0.4%-$56,649.100.01
First Trust$14M0.5394,984-29.71%-$5.92M0.01
Victory Capital Management Inc$13.04M0.47367,704+2,531.91%+$12.54M0.01
AQR Capital$11.13M0.41320,472-41.44%-$7.88M0.02
Glenmede$11.32M0.41319,420+7.7%+$809,748.830.06
HERITAGE ASSET MANAGEMENT INC$11.07M0.4318,730+7.03%+$726,654.840.06
Levin Easterly Partners Llc$10.64M0.38300,059+1.68%+$175,725.660.73
Millennium Management LLC$10.4M0.37293,355-26.12%-$3.68M0.01
Tudor Investment Corp Et Al$9.67M0.35272,783+83.97%+$4.41M0.1
Arrowstreet Capital, Limited Partnership$9.43M0.34266,074-42.09%-$6.86M0.01
Point72 Asset Management$9.03M0.32254,862-17.41%-$1.91M0.01
Raymond James Associates$8.1M0.29228,599+10.31%+$757,601.620.01
Balyasny Asset Management Llc$7.4M0.27208,681+366.86%+$5.81M0.02
Clearline Capital LP$7.13M0.26201,0510%+$00.7
RhumbLine Advisers$7.07M0.25199,491-5.75%-$431,388.430.01
Legal & General$6.61M0.24186,534-5.72%-$401,506.68<0.01
JENNISON ASSOCIATES LLC$6.43M0.23181,299+4.85%+$297,141.92<0.01
Nuveen$6.06M0.22170,815-0.26%-$15,668.90<0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.